Meet Roland

Watch Roland's video

Roland (4 years old), a real VILTEPSO patient and compensated spokesperson. Each patient’s experience is unique.
Ask your doctor if VILTEPSO would be right for you or your loved one.*

Roland's Journey

See how Roland was able to start VILTEPSO soon after being diagnosed with Duchenne, and how he stays entertained during his home infusions.

Watch Roland's story

Roland

What was Roland being diagnosed with Duchenne like?

Amanda White, Roland’s mom
We found out that Roland had Duchenne just before his second birthday. The day after, my brother was like, “You have to keep moving.” So, I just have to work harder, play harder, and love him harder.

It was hard for me with all the genetic stuff. I found out I’m a carrier. That was really difficult, because for the longest time, you feel like it’s your fault. Nick was tremendously supportive, though. I remember one time, all he said to me was, “You know, I love you and Roland.” That’s such a simple statement. But it’s all I need to know.

Roland was diagnosed in February of 2022, and we were able to get VILTEPSO started for him in May of 2022. We had one infusion at the hospital, and then we started home infusions.

Roland

Does Roland taking VILTEPSO give you hope?

Nick White, Roland’s dad

VILTEPSO gives Roland the opportunity to make some dystrophin. So, yes, Roland taking VILTEPSO gives us hope. Just knowing that’s happening. That really helps.

Amanda White, Roland’s mom

We don’t know what the future looks like, but we’re hopeful. We’re really grateful that VILTEPSO was an option for our son.

How does Roland inspire you?

Nick White, Roland’s dad

He’s happy all the time, you know? He’s such a sweet kid. He keeps me going, the light of my life. It just doesn’t get any better.

Roland

What has your family’s journey with Duchenne been like?

Mark Watkins, Roland’s grandfather

Our journey is just over a year old. I’m not going to lie – it was tough at first. But it enabled us to focus on Roland. And I would say that it’s helped us reprioritize the things in our life.

Roland

How would you say Duchenne has affected Roland?

Mark Watkins, Roland’s grandfather

So far, Duchenne has affected Roland just by him being a little bit slower than his peers. He was slower to walk, which is kind of what cued us in.

If you could say one thing to another caregiver of a child with Duchenne, what would it be?

Mark Watkins, Roland’s grandfather

If I could say one thing, it would be to let the emotion pass, and then live for each moment.

Each situation is unique and time to get on therapy will vary from patient to patient.

Roland

Explore some of our other VILTEPSO Heroes

Mason

Mason

11 years old

Hear how Mason gets his weekly infusions at home with a registered nurse, and listen to his mom Rebecca’s...

Diego

Diego

19 years old

Hear Diego’s mom Leslie explain why she moved with her sons to the U.S. so Diego could get access to VILTEPSO,...

Michael

Michael

14 years old

Hear Michael’s brothers describe how Michael views Duchenne as more of a special ability than a disability, and...

*These stories describe unique experiences with VILTEPSO and are not intended to represent the average individual’s response. Individual patient results with VILTEPSO may vary.

Learn about VILTEPSO’s efficacy data, and
the four-year, open-label extension study

See Efficacy & Safety Data
Close
Toggle ISI Open EXPAND

Indication

VILTEPSO is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. This indication is approved under accelerated approval based on an increase in dystrophin production in skeletal muscle observed in patients treated with VILTEPSO. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Important Safety Information

  • In clinical studies, no patients experienced kidney toxicity during treatment with VILTEPSO. However, kidney toxicity from drugs like VILTEPSO may be possible. Your doctor may monitor the health of your kidneys before starting and during treatment with VILTEPSO.
  • Common side effects include upper respiratory tract infection, injection site reaction, cough, and fever.
  • You are encouraged to report adverse events related to VILTEPSO. To do so, or for general inquiries, please call NS Pharma Medical Information at 1-866-NSPHARM (1-866-677-4276).

For more information about VILTEPSO, see full Prescribing Information.

For more information about VILTEPSO, see full Prescribing Information.